APA (7th ed.) Citation

DJ, F., I, T., RB, S., DP, W., NR, S., JP, L., . . . L, A. (2015). Paliperidone palmitate once-monthly reduces risk of relapse of psychotic, depressive, and manic symptoms and maintains functioning in a double-blind, randomized study of schizoaffective disorder. The Journal of clinical psychiatry, 76(3), 253. https://doi.org/10.4088/JCP.14m09416

Chicago Style (17th ed.) Citation

DJ, Fu, Turkoz I, Simonson RB, Walling DP, Schooler NR, Lindenmayer JP, Canuso CM, and Alphs L. "Paliperidone Palmitate Once-monthly Reduces Risk of Relapse of Psychotic, Depressive, and Manic Symptoms and Maintains Functioning in a Double-blind, Randomized Study of Schizoaffective Disorder." The Journal of Clinical Psychiatry 76, no. 3 (2015): 253. https://doi.org/10.4088/JCP.14m09416.

MLA (9th ed.) Citation

DJ, Fu, et al. "Paliperidone Palmitate Once-monthly Reduces Risk of Relapse of Psychotic, Depressive, and Manic Symptoms and Maintains Functioning in a Double-blind, Randomized Study of Schizoaffective Disorder." The Journal of Clinical Psychiatry, vol. 76, no. 3, 2015, p. 253, https://doi.org/10.4088/JCP.14m09416.